Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimonabant versus placebo plus low-fat diet in overweight and obese subjects
2008-001003-38Phase 4Terminated
- Sponsor
- Royal Group of Hospitals
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Overweight, obesity and insulin resistance (IR) comparing Rimonabant arm with Placebo arm (2 arms). Primary endpoint: Insulin resistance by hyperinsulinaemic euglycaemic glucose clamp. Started Jun 2008; status: terminated.
02
Drugs
rimonabant
03
Conditions
Overweightobesityinsulin resistance (IR)
Beyond the preview
Go deeper on 2008-001003-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001003-38.